SE9704404D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9704404D0
SE9704404D0 SE9704404A SE9704404A SE9704404D0 SE 9704404 D0 SE9704404 D0 SE 9704404D0 SE 9704404 A SE9704404 A SE 9704404A SE 9704404 A SE9704404 A SE 9704404A SE 9704404 D0 SE9704404 D0 SE 9704404D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
substituted
formula
treatment
Prior art date
Application number
SE9704404A
Other languages
English (en)
Swedish (sv)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9704404A priority Critical patent/SE9704404D0/xx
Publication of SE9704404D0 publication Critical patent/SE9704404D0/xx
Priority to TW087118942A priority patent/TW515798B/zh
Priority to ARP980105799A priority patent/AR016972A1/es
Priority to ZA9810468A priority patent/ZA9810468B/xx
Priority to MYPI98005216A priority patent/MY121032A/en
Priority to CA002311798A priority patent/CA2311798A1/en
Priority to HU0100601A priority patent/HUP0100601A3/hu
Priority to DK98957270T priority patent/DK1042324T3/da
Priority to NZ504355A priority patent/NZ504355A/en
Priority to CZ20001947A priority patent/CZ292349B6/cs
Priority to PCT/SE1998/002091 priority patent/WO1999028322A1/en
Priority to ES98957270T priority patent/ES2191356T3/es
Priority to UA2000052801A priority patent/UA70932C2/uk
Priority to KR1020007005804A priority patent/KR20010032559A/ko
Priority to SI9830381T priority patent/SI1042324T1/xx
Priority to HK01101145.1A priority patent/HK1030216B/en
Priority to AT98957270T priority patent/ATE233263T1/de
Priority to EEP200000315A priority patent/EE04060B1/xx
Priority to JP2000523214A priority patent/JP2001525322A/ja
Priority to IDW20000987A priority patent/ID24730A/id
Priority to EP98957270A priority patent/EP1042324B1/en
Priority to AU13565/99A priority patent/AU752187C/en
Priority to PT98957270T priority patent/PT1042324E/pt
Priority to CNB98813344XA priority patent/CN1142933C/zh
Priority to BR9814755-2A priority patent/BR9814755A/pt
Priority to TR2000/01530T priority patent/TR200001530T2/xx
Priority to PL98340920A priority patent/PL340920A1/xx
Priority to RU2000113729/04A priority patent/RU2241000C2/ru
Priority to IL13614598A priority patent/IL136145A0/xx
Priority to SK674-2000A priority patent/SK283904B6/sk
Priority to US09/194,823 priority patent/US6518270B1/en
Priority to DE69811735T priority patent/DE69811735T2/de
Priority to IS5486A priority patent/IS5486A/is
Priority to NO20002721A priority patent/NO315704B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9704404A 1997-11-28 1997-11-28 New compounds SE9704404D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds
TW087118942A TW515798B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
ARP980105799A AR016972A1 (es) 1997-11-28 1998-11-16 Compuestos heterociclicos sustituidos con bencilo para la inhibicion de secrecion de acido gastrico, procesos para su preparacion, composicionesfarmaceuticas y uso de los mismos
ZA9810468A ZA9810468B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof
MYPI98005216A MY121032A (en) 1997-11-28 1998-11-17 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
DE69811735T DE69811735T2 (de) 1997-11-28 1998-11-18 Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
AT98957270T ATE233263T1 (de) 1997-11-28 1998-11-18 Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
EP98957270A EP1042324B1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
DK98957270T DK1042324T3 (da) 1997-11-28 1998-11-18 Heterocykliske forbindelser til inhibering af mavesyresekretion, fremgangsmåder til deres fremstilling og farmaceutiske præparater deraf
NZ504355A NZ504355A (en) 1997-11-28 1998-11-18 Imidazopyrazine, pyrrolopyridazine, pyrrolopyridine, pyrrolopyrazine, imidazopyridazine or imidazopyrimidine derivatives substituted by benzoyloxy or benzylamino useful for inhibiting gastric acid secretions
CZ20001947A CZ292349B6 (cs) 1997-11-28 1998-11-18 Heterocyklická sloučenina, způsoby její přípravy a použití a farmaceutická kompozice s jejím obsahem
PCT/SE1998/002091 WO1999028322A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
ES98957270T ES2191356T3 (es) 1997-11-28 1998-11-18 Compuestos heterociclicos para la inhibicion de la secrecion de acidos gastricos, procedimientos para su preparacion y composiciones farmaceuticas de ellos.
UA2000052801A UA70932C2 (uk) 1997-11-28 1998-11-18 Гетероциклічні сполуки для пригнічення кислотності шлункового секрету, спосіб їх одержання (варіанти) та фармацевтична композиція, що їх містить (варіанти)
KR1020007005804A KR20010032559A (ko) 1997-11-28 1998-11-18 위산 분비 억제용 헤테로고리 화합물, 그의 제조 방법 및그의 제약 조성물
SI9830381T SI1042324T1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
HK01101145.1A HK1030216B (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
CA002311798A CA2311798A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
EEP200000315A EE04060B1 (et) 1997-11-28 1998-11-18 Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
JP2000523214A JP2001525322A (ja) 1997-11-28 1998-11-18 胃酸分泌を抑制する複素環式化合物、それらの製造法およびそれらの医薬組成物
IDW20000987A ID24730A (id) 1997-11-28 1998-11-18 Senyawa-senyawa heterosiklik untuk penghambatan sekresi asam lambung, proses pembuatan dan komposisi-komposisi farmasinya
HU0100601A HUP0100601A3 (en) 1997-11-28 1998-11-18 Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof
AU13565/99A AU752187C (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
PT98957270T PT1042324E (pt) 1997-11-28 1998-11-18 Compostos heterociclicos para inibicao da secrecaode acido gastrico processis para a sua prepara cao e suas composicoes farmaceuticas
CNB98813344XA CN1142933C (zh) 1997-11-28 1998-11-18 抑制胃酸分泌的杂环化合物、其制备方法及其药物组合物
BR9814755-2A BR9814755A (pt) 1997-11-28 1998-11-18 Composto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para inibir a secreção do ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais, e para o tratamento ou profilaxia de condições que envolvam infecção por helicobacter pylori da mucosa gástrica humana
TR2000/01530T TR200001530T2 (tr) 1997-11-28 1998-11-18 Gastrik asit salgılamasının önlenmesi için heterosiklik bileşimler
PL98340920A PL340920A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds
RU2000113729/04A RU2241000C2 (ru) 1997-11-28 1998-11-18 Гетероциклические соединения с замещенной фенильной группировкой, способ их получения (варианты), фармацевтические препараты на их основе и способ ингибирования секреции желудочной кислоты
IL13614598A IL136145A0 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
SK674-2000A SK283904B6 (sk) 1997-11-28 1998-11-18 Heterocyklické zlúčeniny na inhibíciu sekrécie žalúdočnej kyseliny, spôsoby ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
US09/194,823 US6518270B1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IS5486A IS5486A (is) 1997-11-28 2000-05-10 Heterósýklísk efnasambönd til að hindra magasýruflæði, aðferðir við framleiðslu þeirra og lyfjablöndur er innihalda þau
NO20002721A NO315704B1 (no) 1997-11-28 2000-05-26 Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Publications (1)

Publication Number Publication Date
SE9704404D0 true SE9704404D0 (sv) 1997-11-28

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Country Status (32)

Country Link
US (1) US6518270B1 (cs)
EP (1) EP1042324B1 (cs)
JP (1) JP2001525322A (cs)
KR (1) KR20010032559A (cs)
CN (1) CN1142933C (cs)
AR (1) AR016972A1 (cs)
AT (1) ATE233263T1 (cs)
AU (1) AU752187C (cs)
BR (1) BR9814755A (cs)
CA (1) CA2311798A1 (cs)
CZ (1) CZ292349B6 (cs)
DE (1) DE69811735T2 (cs)
DK (1) DK1042324T3 (cs)
EE (1) EE04060B1 (cs)
ES (1) ES2191356T3 (cs)
HU (1) HUP0100601A3 (cs)
ID (1) ID24730A (cs)
IL (1) IL136145A0 (cs)
IS (1) IS5486A (cs)
MY (1) MY121032A (cs)
NO (1) NO315704B1 (cs)
NZ (1) NZ504355A (cs)
PL (1) PL340920A1 (cs)
PT (1) PT1042324E (cs)
RU (1) RU2241000C2 (cs)
SE (1) SE9704404D0 (cs)
SK (1) SK283904B6 (cs)
TR (1) TR200001530T2 (cs)
TW (1) TW515798B (cs)
UA (1) UA70932C2 (cs)
WO (1) WO1999028322A1 (cs)
ZA (1) ZA9810468B (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE355375T1 (de) 1996-01-04 2006-03-15 Novartis Vaccines & Diagnostic Bakterioferritin aus helicobacter pylori
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
UY26380A1 (es) * 1999-10-08 2001-04-30 Smithkline Beecham Corp Inhibidores de fab i
ES2320984T3 (es) * 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
CN100537571C (zh) * 2002-04-19 2009-09-09 细胞基因组公司 咪唑并[1,2-а]吡嗪-8-基胺,其制备方法及使用方法
US7312341B2 (en) 2002-09-09 2007-12-25 Cgi Pharmaceuticals, Inc. 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
WO2004029057A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 内臓痛の治療または予防のための医薬組成物
WO2004029058A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 血中ガストリン濃度上昇の抑制のための医薬組成物
JP4859460B2 (ja) * 2002-12-06 2012-01-25 アフィニウム ファーマシューティカルズ， インク． ヘテロ環化合物、その製造方法および治療におけるその使用
WO2004072081A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
WO2005005429A1 (en) 2003-06-30 2005-01-20 Cellular Genomics, Inc. Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
WO2005019220A2 (en) 2003-08-11 2005-03-03 Cellular Genomics Inc. Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
CA2568914C (en) 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
KR20070053231A (ko) * 2004-07-28 2007-05-23 다케다 야쿠힌 고교 가부시키가이샤 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도
CA2575345A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
US7662832B2 (en) * 2004-09-03 2010-02-16 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
JP4989477B2 (ja) * 2004-09-03 2012-08-01 ユーハン・コーポレイション ピロロ［３，２−ｃ］ピリジン誘導体及びその製造方法
EP1784402B1 (en) 2004-09-03 2011-08-03 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
ES2426920T3 (es) * 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
CA2620223A1 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
AR061229A1 (es) 2006-06-06 2008-08-13 Schering Corp Imidazopirazinas como inhibidores de la proteina quinasa
US8318720B2 (en) * 2006-07-20 2012-11-27 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as Fab I inhibitors
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
WO2009102468A1 (en) 2008-02-13 2009-08-20 Cgi Pharmaceuticals, Inc. 6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof
ES2744541T3 (es) 2008-12-08 2020-02-25 Gilead Connecticut Inc Inhibidores de imidazopirazina Syk
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
KR101748925B1 (ko) 2008-12-08 2017-06-19 질레드 코네티컷 인코포레이티드 이미다조피라진 ｓｙｋ 억제제
ES2530449T3 (es) 2010-03-11 2015-03-02 Gilead Connecticut Inc Inhibidores de Syk de imidazopiridinas
JP6085026B2 (ja) 2012-06-19 2017-02-22 デビオファーム インターナショナル エスエーＤｅｂｉｏｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓａ （ｅ）−ｎ−メチル−ｎ−（（３−メチルベンゾフラン−２−イル）メチル）−３−（７−オキソ−５，６，７，８−テトラヒドロ−１，８−ナフチリジン−３−イル）アクリルアミドのプロドラッグ誘導体
AP2016009007A0 (en) 2013-07-30 2016-01-31 Gilead Connecticut Inc Formulation of syk inhibitors
DK3027618T3 (da) 2013-07-30 2020-10-12 Kronos Bio Inc Polymorf af syk-hæmmere
KR20180002888A (ko) 2013-12-04 2018-01-08 길리애드 사이언시즈, 인코포레이티드 암을 치료하는 방법
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
UY35898A (es) 2013-12-23 2015-07-31 Gilead Sciences Inc ?compuestos inhibidores de syk y composiciones que los comprenden?.
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
SG11201610551TA (en) 2014-07-14 2017-01-27 Gilead Sciences Inc Combinations for treating cancers
EP3419628B1 (en) 2016-02-26 2020-10-14 Debiopharm International SA Medicament for treatment of diabetic foot infections
AU2018321264A1 (en) 2017-08-25 2020-02-27 Kronos Bio, Inc. Polymorphs of Syk inhibitors
WO2020165407A1 (en) 2019-02-14 2020-08-20 Debiopharm International S.A. Afabicin formulation, method for making the same
MX2021010131A (es) 2019-02-22 2021-11-18 Kronos Bio Inc Formas sólidas de pirazinas condensadas a manera de inhibidores de syk.
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス．エー． バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) * 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
IL97931A0 (en) 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5041442A (en) * 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
WO1992006979A1 (de) * 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
DK0609328T3 (da) * 1991-10-25 1999-10-25 Byk Gulden Lomberg Chem Fab Pyrrolo-pyridaziner med gastro-intestinal beskyttelsesvirkning
EP0742218B1 (en) * 1994-01-19 2002-12-04 Sankyo Company Limited Pyrrolopyridazine derivative
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
KR20010032559A (ko) 2001-04-25
NO315704B1 (no) 2003-10-13
AU752187B2 (en) 2002-09-12
CA2311798A1 (en) 1999-06-10
MY121032A (en) 2005-12-30
CZ20001947A3 (cs) 2000-11-15
WO1999028322A1 (en) 1999-06-10
BR9814755A (pt) 2000-10-03
DE69811735D1 (de) 2003-04-03
EP1042324B1 (en) 2003-02-26
IS5486A (is) 2000-05-10
PT1042324E (pt) 2003-06-30
TW515798B (en) 2003-01-01
JP2001525322A (ja) 2001-12-11
AU752187C (en) 2003-09-18
HUP0100601A2 (hu) 2001-09-28
EE200000315A (et) 2001-10-15
EE04060B1 (et) 2003-06-16
HUP0100601A3 (en) 2002-10-28
NZ504355A (en) 2001-12-21
TR200001530T2 (tr) 2000-11-21
PL340920A1 (en) 2001-03-12
NO20002721D0 (no) 2000-05-26
EP1042324A1 (en) 2000-10-11
ZA9810468B (en) 1999-05-21
RU2241000C2 (ru) 2004-11-27
DK1042324T3 (da) 2003-05-05
DE69811735T2 (de) 2003-12-18
AU1356599A (en) 1999-06-16
AR016972A1 (es) 2001-08-01
SK6742000A3 (en) 2001-03-12
CN1142933C (zh) 2004-03-24
NO20002721L (no) 2000-07-28
ID24730A (id) 2000-08-03
UA70932C2 (uk) 2004-11-15
ES2191356T3 (es) 2003-09-01
CN1284078A (zh) 2001-02-14
US6518270B1 (en) 2003-02-11
CZ292349B6 (cs) 2003-09-17
SK283904B6 (sk) 2004-04-06
IL136145A0 (en) 2001-05-20
HK1030216A1 (en) 2001-04-27
ATE233263T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
SE9704404D0 (sv) New compounds
SE9700661D0 (sv) New compounds
SE9801526D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9802794D0 (sv) New compounds
NZ510180A (en) Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
FI970246A7 (fi) Dihydrobentsofuraanit
SE9802793D0 (sv) New compounds
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
DE60121345D1 (de) Alkylierte imidazopyridinderivate
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
NO995289L (no) Benzimidazol-derivater
TR199801903A2 (xx) Sulfonamid ikameli ve bunlar� i�eren farmakolojik bile�imler.
ATE196134T1 (de) Substituierte chinolinderivate, und ihre verwendung als inhibitoren der magensekretion
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
FR2631029B2 (fr) Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmacologiquement compatibles